BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Visani M, Acquaviva G, De Leo A, Sanza V, Merlo L, Maloberti T, Brandes AA, Franceschi E, Di Battista M, Masetti M, Jovine E, Fiorino S, Pession A, Tallini G, de Biase D. Molecular alterations in pancreatic tumors. World J Gastroenterol 2021; 27(21): 2710-2726 [PMID: 34135550 DOI: 10.3748/wjg.v27.i21.2710]
URL: https://www.wjgnet.com/2150-5330/full/v27/i21/2710.htm
Number Citing Articles
1
Aditya V. Shreenivas, Shumei Kato, Jingjing Hu, Catherine Skefos, Jason Sicklick, Razelle Kurzrock. Carcinoma of unknown primary: Molecular tumor board‐based therapyCA: A Cancer Journal for Clinicians 2022; 72(6): 510 doi: 10.3322/caac.21748
2
Deborah Malvi, Francesco Vasuri, Thais Maloberti, Viviana Sanza, Antonio De Leo, Adele Fornelli, Michele Masetti, Claudia Benini, Raffaele Lombardi, Maria Fortuna Offi, Mariacristina Di Marco, Matteo Ravaioli, Sirio Fiorino, Enrico Franceschi, Alba A. Brandes, Elio Jovine, Antonietta D’Errico, Giovanni Tallini, Dario de Biase. Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene PanelDiagnostics 2022; 12(5): 1058 doi: 10.3390/diagnostics12051058
3
Julie Weigner, Raewyn Billings, Rodney J. Scott, Simon King. The utilisation of digital droplet PCR to enhance the diagnosis of bladder and pancreaticobiliary tumours in cytology specimensDiagnostic Cytopathology 2023; 51(8): 511 doi: 10.1002/dc.25151
4
Carla Limeira Barreto, Cristiana de Lima Tavares, France Anne Reinaldo Maia, David Arruda Tavares de Queiroz Marques. Tumor de Frantz: relato de três casosJournal Archives of Health 2024; 5(1): 260 doi: 10.46919/archv5n1-022
5
Rong Xia, Xiaoying Liu, Cristina H. Hajdu, Wenqing Cao, James N. Kaz, Tamas Gonda, Aylin Simsir. The utility of molecular studies on pancreatic cystic lesions: A comprehensive reviewHuman Pathology Reports 2024; 36: 300741 doi: 10.1016/j.hpr.2024.300741
6
Couvineau Alain, Nicole Pascal, Gratio Valérie, Voisin Thierry. Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging TargetMolecules 2021; 26(16): 4849 doi: 10.3390/molecules26164849
7
Miguel S. Gonzalez‐Mancera, Saman S. Ahmadian, Carmen Gomez‐Fernandez, Jaylou Velez‐Torres, Merce Jorda, Monica T. García‐Buitrago. Risk of malignancy associated with the diagnostic categories proposed by the Papanicolaou Society of Cytopathology for pancreaticobiliary specimens: An institutional experienceDiagnostic Cytopathology 2022; 50(2): 49 doi: 10.1002/dc.24910
8
Kai Li, Qian Wang, Hua Bian, Zhiguo Chen, Haifa He, Xulin Zhao, Pengju Gong. Comprehensive Analysis Reveals USP45 as a Novel Putative Oncogene in Pan-CancerFrontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.886904
9
Alain Couvineau, Pascal Nicole, Valérie Gratio, Thierry Voisin. The Orexin receptors: Structural and anti-tumoral propertiesFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.931970
10
Antonio De Leo, Gloria Ravegnini, Francesco Musiani, Thais Maloberti, Michela Visani, Viviana Sanza, Sabrina Angelini, Anna Myriam Perrone, Pierandrea De Iaco, Angelo Gianluca Corradini, Francesca Rosini, Marco Grillini, Donatella Santini, Claudio Ceccarelli, Claudio Zamagni, Giovanni Tallini, Dario de Biase. Relevance of ARID1A Mutations in Endometrial CarcinomasDiagnostics 2022; 12(3): 592 doi: 10.3390/diagnostics12030592
11
Luis Marti-Bonmati, Leonor Cerdá-Alberich, Alexandre Pérez-Girbés, Roberto Díaz Beveridge, Eva Montalvá Orón, Judith Pérez Rojas, Angel Alberich-Bayarri. Pancreatic cancer, radiomics and artificial intelligenceThe British Journal of Radiology 2022; 95(1137) doi: 10.1259/bjr.20220072
12
Bo Franzén, Gert Auer, Rolf Lewensohn. Minimally invasive biopsy‐based diagnostics in support of precision cancer medicineMolecular Oncology 2024;  doi: 10.1002/1878-0261.13640
13
Leonel Pekarek, Oscar Fraile‑Μartinez, Cielo Garcia‑Montero, Miguel Alvarez‑Mon, Julio Acero, Lidia Ruiz‑Llorente, Natalio García‑Honduvilla, Agustin Albillos, Julia Buján, Melchor Alvarez‑Mon, Luis Guijarro, Miguel Ortega. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review)Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13070
14
Shirin Hafezi, Maha Saber-Ayad, Wael M. Abdel-Rahman. Highlights on the Role of KRAS Mutations in Reshaping the Microenvironment of Pancreatic AdenocarcinomaInternational Journal of Molecular Sciences 2021; 22(19): 10219 doi: 10.3390/ijms221910219
15
Akash Bararia, Amlan Das, Sangeeta Mitra, Sudeep Banerjee, Aniruddha Chatterjee, Nilabja Sikdar. Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathwaysWorld Journal of Gastrointestinal Oncology 2023; 15(9): 1505-1519 doi: 10.4251/wjgo.v15.i9.1505